Moxetumomab pasudotox and Risedronate Delayed-Release Tablets
Determining the interaction of Moxetumomab pasudotox and Risedronate Delayed-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
Generic Name: risedronate
Brand name: Actonel, Atelvia
Synonyms: Risedronate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-Risedronate Sodium
- Moxetumomab pasudotox-Risedronate Tablets
- Moxetumomab pasudotox-Risperdal
- Moxetumomab pasudotox-Risperdal (Risperidone Oral Solution)
- Moxetumomab pasudotox-Risperdal (Risperidone Tablets)
- Moxetumomab pasudotox-Risperdal Consta
- Risedronate Delayed-Release Tablets-Moxetumomab Pasudotox-tdfk
- Risedronate Delayed-Release Tablets-Moxetumomab pasudotox-tdfk Intravenous
- Risedronate Delayed-Release Tablets-Moxifloxacin
- Risedronate Delayed-Release Tablets-Moxifloxacin (Systemic)
- Risedronate Delayed-Release Tablets-Moxifloxacin Hydrochloride
- Risedronate Delayed-Release Tablets-Moxifloxacin Injection